Nifty
Sensex
:
:
23587.50
78041.59
-364.20 (-1.52%)
-1176.46 (-1.49%)

Pharmaceuticals & Drugs

Rating :
N/A

BSE: 543349 | NSE: AMIORG

2120.40
20-Dec-2024
  • Open
  • High
  • Low
  • Previous Close
  •  2118.10
  •  2178.70
  •  2107.10
  •  2096.90
  • Volume
  • Traded Value (lacs)
  • 52 Week High
  • 52 Week Low
  •  178972
  •  3830.99
  •  2320.40
  •  1004.45

Stock Summary

  • Market Cap(Crs)
  • Stock P:E
  • Face Value
  • 8,672.17
  • 93.07
  • 10
  • Enterprise Value(Crs)
  • Dividend Yield
  • Price:Book Value
  • 8,398.83
  • 0.14%
  • 7.21

Shareholding Pattern

  • Promoter
  • Corporate
  • Public
  • 35.97%
  • 1.99%
  • 24.73%
  • FII
  • DII
  • Others
  • 13.87%
  • 17.28%
  • 6.16%

Chart

Price | P:E | P:BV | EV:EBITDA | MCap:Sales | EPS

Revenue CAGR (%)

  • 10 Years
  • 5 Years
  • 3 Years
  • 19.92
  • 24.52
  • 11.32

EBITDA CAGR (%)

  • 10 Years
  • 5 Years
  • 3 Years
  • 29.21
  • 25.66
  • 4.09

PAT CAGR (%)

  • 10 Years
  • 5 Years
  • 3 Years
  • 26.72
  • 9.26
  • -15.91

P:E (Median)

  • 8 Years
  • 5 Years
  • 3 Years
  • -
  • -
  • 58.26

P:BV (Average)

  • 8 Years
  • 5 Years
  • 3 Years
  • -
  • -
  • 6.59

EV:EBITDA (Average)

  • 8 Years
  • 5 Years
  • 3 Years
  • -
  • -
  • 36.82

Earnings Forecasts:

Description
2024
2025
2026
2027
Adj EPS
11.67
28.87
43.42
66
P/E Ratio
182.02
73.57
48.92
32.18
Revenue
717
932
1188
1568
EBITDA
128
180
263
377
Net Income
43
117
179
266
ROA
4.6
10.1
11.8
14.7
P/Bk Ratio
11.62
7.54
6.74
5.12
ROE
6.75
12.89
15.73
17.2
FCFF
-159.39
-184.34
53.38
87.35
FCFF Yield
-1.78
-2.06
0.6
0.97

Quarterly Results

Consolidated Figures in Rs. Crores /

Standalone
Description
Sep 24
Sep 23
Var%
Jun 24
Jun 23
Var%
Mar 24
Mar 23
Var%
Dec 23
Dec 22
Var%
Net Sales
246.73
172.36
43.15%
176.67
153.72
14.93%
224.96
186.38
20.70%
166.44
152.36
9.24%
Expenses
197.80
147.54
34.07%
147.15
119.71
22.92%
181.80
145.53
24.92%
139.94
121.56
15.12%
EBITDA
48.93
24.81
97.22%
29.52
34.01
-13.20%
43.16
40.86
5.63%
26.51
30.80
-13.93%
EBIDTM
19.83%
14.40%
16.71%
22.12%
19.19%
21.92%
15.93%
20.21%
Other Income
8.44
1.50
462.67%
1.04
1.15
-9.57%
1.34
-0.17
-
3.49
3.02
15.56%
Interest
0.50
0.82
-39.02%
4.43
0.51
768.63%
2.07
0.59
250.85%
2.54
1.19
113.45%
Depreciation
6.83
3.69
85.09%
6.18
3.71
66.58%
4.90
3.43
42.86%
3.76
3.06
22.88%
PBT
50.04
-9.94
-
19.96
30.94
-35.49%
37.20
36.66
1.47%
23.70
29.57
-19.85%
Tax
12.47
7.08
76.13%
5.26
8.70
-39.54%
11.53
9.46
21.88%
5.89
7.28
-19.09%
PAT
37.57
-17.02
-
14.69
22.24
-33.95%
25.68
27.20
-5.59%
17.81
22.28
-20.06%
PATM
15.23%
-9.87%
8.31%
14.47%
11.41%
14.59%
10.70%
14.62%
EPS
9.12
-5.11
-
3.41
5.41
-36.97%
6.82
7.46
-8.58%
4.54
6.12
-25.82%

Annual Results

Standalone Figures in Rs. Crores /

Consolidated
Description
TTM
Mar 24
Mar 23
Mar 22
Mar 21
Mar 20
Mar 18
Mar 17
Mar 16
Net Sales
814.80
717.47
616.73
520.13
340.61
239.64
188.22
160.26
153.70
Net Sales Growth
22.56%
16.33%
18.57%
52.71%
42.13%
27.32%
17.45%
4.27%
 
Cost Of Goods Sold
471.89
411.69
330.89
272.83
179.68
128.91
112.95
95.00
91.50
Gross Profit
342.91
305.79
285.84
247.30
160.92
110.73
75.27
65.27
62.21
GP Margin
42.09%
42.62%
46.35%
47.55%
47.24%
46.21%
39.99%
40.73%
40.47%
Total Expenditure
666.69
588.98
494.13
414.96
260.45
198.63
157.70
137.13
135.51
Power & Fuel Cost
-
25.82
22.28
21.40
5.26
4.54
1.27
1.00
1.26
% Of Sales
-
3.60%
3.61%
4.11%
1.54%
1.89%
0.67%
0.62%
0.82%
Employee Cost
-
63.11
48.84
41.37
21.01
17.81
9.89
7.38
7.02
% Of Sales
-
8.80%
7.92%
7.95%
6.17%
7.43%
5.25%
4.61%
4.57%
Manufacturing Exp.
-
47.35
46.98
49.66
41.32
34.60
19.87
15.42
14.41
% Of Sales
-
6.60%
7.62%
9.55%
12.13%
14.44%
10.56%
9.62%
9.38%
General & Admin Exp.
-
12.97
9.93
7.30
4.46
4.72
8.59
13.68
15.24
% Of Sales
-
1.81%
1.61%
1.40%
1.31%
1.97%
4.56%
8.54%
9.92%
Selling & Distn. Exp.
-
19.88
26.49
19.92
7.01
5.79
3.97
3.92
5.36
% Of Sales
-
2.77%
4.30%
3.83%
2.06%
2.42%
2.11%
2.45%
3.49%
Miscellaneous Exp.
-
8.15
8.71
2.49
1.72
2.26
1.16
0.74
0.73
% Of Sales
-
1.14%
1.41%
0.48%
0.50%
0.94%
0.62%
0.46%
0.47%
EBITDA
148.12
128.49
122.60
105.17
80.16
41.01
30.52
23.13
18.19
EBITDA Margin
18.18%
17.91%
19.88%
20.22%
23.53%
17.11%
16.22%
14.43%
11.83%
Other Income
14.31
7.49
4.32
2.76
1.38
2.84
2.96
0.21
2.87
Interest
9.54
5.94
2.41
6.41
5.62
5.59
3.23
3.30
2.56
Depreciation
21.67
16.06
12.34
10.08
4.19
3.52
1.91
1.37
0.80
PBT
130.90
113.99
112.17
91.45
71.73
34.75
28.35
18.68
17.70
Tax
35.15
33.19
28.88
19.50
17.73
7.28
9.85
6.63
5.04
Tax Rate
26.85%
40.52%
25.75%
21.32%
24.72%
20.95%
34.74%
35.49%
28.47%
PAT
95.75
42.78
83.29
71.95
54.00
27.47
18.50
12.05
12.66
PAT before Minority Interest
93.18
48.71
83.29
71.95
54.00
27.47
18.50
12.05
12.66
Minority Interest
-2.57
-5.93
0.00
0.00
0.00
0.00
0.00
0.00
0.00
PAT Margin
11.75%
5.96%
13.51%
13.83%
15.85%
11.46%
9.83%
7.52%
8.24%
PAT Growth
75.05%
-48.64%
15.76%
33.24%
96.58%
48.49%
53.53%
-4.82%
 
EPS
23.41
10.46
20.36
17.59
13.20
6.72
4.52
2.95
3.10

Results Balance Sheet

Standalone Figures in Rs. Crores /

Consolidated
Description
Mar 24
Mar 23
Mar 22
Mar 21
Mar 20
Mar 18
Mar 17
Mar 16
Shareholder's Funds
674.00
593.96
522.27
166.93
111.81
57.68
38.99
27.42
Share Capital
36.88
36.44
36.44
31.50
10.50
1.50
1.50
1.50
Total Reserves
634.81
557.52
485.84
135.43
101.31
56.18
37.49
25.92
Non-Current Liabilities
127.98
10.13
7.29
80.29
25.46
32.73
15.09
15.21
Secured Loans
113.64
0.63
0.59
71.82
12.59
28.10
14.03
13.94
Unsecured Loans
0.00
0.00
0.00
0.82
7.31
3.68
0.47
2.05
Long Term Provisions
1.32
0.68
0.44
4.37
2.44
0.98
0.63
0.37
Current Liabilities
285.17
162.85
129.32
166.04
94.61
65.00
54.82
48.60
Trade Payables
134.61
142.05
118.42
84.78
51.45
47.76
38.43
28.42
Other Current Liabilities
64.78
6.64
4.88
34.62
8.84
3.36
4.99
5.07
Short Term Borrowings
72.59
2.77
0.00
44.53
33.92
9.48
9.06
11.49
Short Term Provisions
13.20
11.39
6.02
2.12
0.41
4.40
2.34
3.63
Total Liabilities
1,095.91
766.94
658.88
413.26
231.88
155.41
108.90
91.23
Net Block
427.16
258.95
204.53
186.31
85.19
31.54
27.76
18.48
Gross Block
498.49
297.69
231.14
202.83
97.78
41.13
35.45
24.81
Accumulated Depreciation
71.33
38.74
26.60
16.52
12.59
9.60
7.69
6.32
Non Current Assets
600.09
309.81
229.31
190.83
110.86
66.45
42.30
24.90
Capital Work in Progress
125.42
29.80
2.96
0.20
11.71
30.32
11.42
3.77
Non Current Investment
0.20
1.65
1.71
1.43
1.73
2.55
1.43
1.37
Long Term Loans & Adv.
46.08
17.20
14.23
1.65
2.68
0.76
0.54
0.48
Other Non Current Assets
1.23
2.21
5.87
1.25
9.55
1.28
1.15
0.80
Current Assets
495.81
457.13
429.57
216.23
121.04
87.19
66.48
66.17
Current Investments
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Inventories
156.73
119.17
112.17
60.36
52.34
27.39
19.72
19.64
Sundry Debtors
206.35
230.26
163.70
120.69
56.40
49.97
36.49
36.30
Cash & Bank
53.31
58.67
99.55
2.68
3.82
1.17
3.58
0.51
Other Current Assets
79.42
7.95
11.09
11.73
8.47
8.67
6.68
9.72
Short Term Loans & Adv.
74.98
41.08
43.05
20.76
8.31
8.54
6.29
9.48
Net Current Assets
210.64
294.28
300.25
50.19
26.42
22.19
11.66
17.57
Total Assets
1,095.90
766.94
658.88
413.26
231.90
155.41
108.90
91.24

Cash Flow

Standalone Figures in Rs. Crores /

Consolidated
Description
Mar 24
Mar 23
Mar 22
Mar 21
Mar 20
Mar 18
Mar 17
Mar 16
Cash From Operating Activity
125.17
65.53
-11.93
27.96
27.08
8.46
28.54
9.86
PBT
81.90
112.17
91.45
71.73
34.75
28.35
18.68
17.70
Adjustment
49.79
14.09
13.64
8.02
10.17
4.43
4.07
2.66
Changes in Working Capital
17.82
-36.28
-94.21
-37.61
-9.44
-16.54
12.56
-7.53
Cash after chg. in Working capital
149.52
89.98
10.88
42.14
35.49
16.24
35.31
12.83
Interest Paid
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Tax Paid
-24.35
-24.45
-22.81
-14.18
-8.41
-7.78
-6.78
-2.98
Other Direct Exp. Paid
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Extra & Other Items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Cash From Investing Activity
-365.39
-33.04
-120.72
-101.21
-23.94
-25.32
-18.61
-14.23
Net Fixed Assets
-245.28
-83.19
-30.11
-90.85
-31.67
-21.20
-14.99
Net Investments
-34.28
-0.05
-0.16
-5.35
-6.72
-5.77
-4.04
Others
-85.83
50.20
-90.45
-5.01
14.45
1.65
0.42
Cash from Financing Activity
239.36
-12.25
140.26
72.11
0.19
14.62
-7.11
4.37
Net Cash Inflow / Outflow
-0.86
20.24
7.61
-1.14
3.33
-2.23
2.82
-0.01
Opening Cash & Equivalents
30.53
10.30
2.68
3.82
0.49
3.14
0.32
0.33
Closing Cash & Equivalent
29.70
30.53
10.30
2.68
3.82
0.90
3.14
0.32

Financial Ratios

Standalone /

Consolidated
Description
Mar 24
Mar 23
Mar 22
Mar 21
Mar 20
Mar 18
Mar 17
Mar 16
Book Value (Rs.)
182.13
163.01
143.34
17.01
106.49
372.75
259.14
181.71
ROA
5.23%
11.68%
13.42%
16.74%
12.34%
13.99%
12.04%
13.87%
ROE
7.70%
14.92%
21.07%
39.63%
28.31%
39.03%
36.44%
46.43%
ROCE
11.81%
20.45%
23.85%
33.01%
26.25%
38.24%
35.91%
35.54%
Fixed Asset Turnover
1.80
2.33
2.40
2.27
2.54
4.92
5.32
6.20
Receivable days
111.06
116.58
99.79
94.89
100.90
83.83
82.89
86.20
Inventory Days
70.18
68.46
60.54
60.39
69.31
45.68
44.82
46.64
Payable days
122.64
143.66
135.92
138.36
169.65
99.64
97.78
86.73
Cash Conversion Cycle
58.60
41.38
24.41
16.92
0.56
29.87
29.93
46.11
Total Debt/Equity
0.32
0.01
0.00
0.85
0.53
0.78
0.68
1.09
Interest Cover
14.79
47.50
15.27
13.77
7.22
9.79
6.67
7.92

News Update:


  • Ami Organics gets nod to enhance capital expenditure for brownfield project
    12th Dec 2024, 10:30 AM

    The company has received approval to enhance capital expenditure amounting upto total cost of Rs 177 crore

    Read More
  • AMI Organics - Quarterly Results
    29th Oct 2024, 12:10 PM

    Read More

Source: www.accordfintech.com | DISCLAIMER: Information is provided " as is" and solely for informational purposes, not for trading purposes or advice, and may be delayed.